No Data
Growth 250 slightly declines, while Syns etc. rise = Emerging Markets, 24th.
The Tokyo Stock Exchange Growth Market 250 Index has slightly declined. Major stocks showed mixed performance, resulting in a lack of direction for the index. Space ventures such as Synspective <290A.T>, QPS Research <5595.T>, and Astroscale Holdings <186A.T> have risen. On the other hand, Sanbio <4592.T>, Trial <141A.T>, and Cover <5253.T> were sold off. The IPO (initial public offering) LIFE CREATE <352A.T> started with a modest increase.
SanBio: Extraordinary Report
Growth 250 continues to decline slightly, with Sambaio and others being sold off = Emerging Markets, 23rd.
The Tokyo Stock Exchange Growth Market 250 Index fell slightly. While the overall Tokyo market rose significantly due to the increase in U.S. stocks, the Growth Market was sluggish and fluctuated around the previous day's closing price. Sunbio <4592.T>, ABEJA <5574.T>, and Free <4478.T> were soft. QPS Research Institute <5595.T>, ispace <9348.T>, and Makuake <4479.T> were bought. The recently listed IPO, Digital Grid <350A.T>, rose initially before selling off.
SanBio: Confirmation
SanBio: Financial Report - 12th Term (2024/02/01 - 2025/01/31)
Stocks that moved and those that were traded in the front market.
* GMO Internet <4784> 2836 +287 capital tends to gather easily during overall market downturns. * Japan Agrochemicals <4997> 834 +44 speculations on the fate of ADEKA's shareholding. * Yamazen <8051> 1425 +71 expectations of lower overseas procurement prices may be a background factor. * Mitsui Sumitomo Construction <1821> 479 +24 continued material view regarding activist buyouts. * Japan Communications <9424> 158 +6 the strength of relative buying assurance and value perception.
